Log In
Print
BCIQ
Print
Print this Print this
 

Ampligen, rintatolimod

  Manage Alerts
Collapse Summary General Information
Company Hemispherx Biopharma Inc.
DescriptionDouble-stranded RNA antiviral agent that agonizes toll-like receptor 3 (TLR3)
Molecular Target 2',5'-oligoadenylate synthetase 1, 40-46kDa (OAS1) ; Toll-like receptor 3 (TLR3)
Mechanism of ActionImmune modulation; Toll-like receptor 3 (TLR3) agonist
Therapeutic ModalityNucleic acid

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today